Nathalie M. Rieser

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Psychedelics in Mental Health: Opportunities and Challenges.

Psychedelics in Mental Health: Opportunities and Challenges.

Journal: Brain and behavior

Published: July 09, 2026

Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.

Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: January 05, 2026

Effects of Psychedelic Drug Use on Neurocognitive Function and Psychological and Social Quality of Life Domains: An International Online Study.

Effects of Psychedelic Drug Use on Neurocognitive Function and Psychological and Social Quality of Life Domains: An International Online Study.

Journal: medRxiv : the preprint server for health sciences

Published: October 01, 2025

Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder.

Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder.

Journal: Translational psychiatry

Published: September 23, 2025

A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.

A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.

Journal: Psychedelic medicine (New Rochelle, N.Y.)

Published: May 12, 2025

The emotional architecture of the psychedelic brain.

The emotional architecture of the psychedelic brain.

Journal: Trends in cognitive sciences

Published: April 11, 2025

Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial.

Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial.

Journal: EClinicalMedicine

Published: October 28, 2024

N-acetylcysteine reduces prefrontal reactivity to cocaine cues in individuals with cocaine use disorder.

N-acetylcysteine reduces prefrontal reactivity to cocaine cues in individuals with cocaine use disorder.

Journal: Frontiers in psychiatry

Published: August 31, 2024

Neurobiological Correlates of Psychedelic Experiences and Psychedelic-Associated Adverse Effects.

Neurobiological Correlates of Psychedelic Experiences and Psychedelic-Associated Adverse Effects.

Journal: Current topics in behavioral neurosciences

Published: July 30, 2024

Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.

Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.

Journal: EClinicalMedicine

Published: February 07, 2023

Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.

Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.

Journal: Biological psychiatry. Cognitive neuroscience and neuroimaging

Published: February 06, 2023

Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences.

Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences.

Journal: Scientific reports

Published: November 07, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026